Literature DB >> 19913310

Cardioembolic outcomes in stress-related cardiomyopathy complicated by ventricular thrombus: a systematic review of 26 clinical studies.

Cesare de Gregorio1.   

Abstract

BACKGROUND: The stress-related cardiomyopathy (SRC) is a relatively novel cardiac syndrome characterized by peculiar transient left ventricular dysfunction, which accounts for approximately 1-3% of patients with symptoms that initially appear to be an acute coronary syndrome. To date, the true incidence and clinical significance of left ventricular thrombus and related embolic outcomes in these patients have not been fully established.
METHODS: The present systematic review aimed to report updated case series of SRC patients with left ventricular thrombus and/or cardioembolic events complicating the course of syndrome, in an attempt to summarize their demographic and clinical characteristics.
RESULTS: Overall, 33 eligible studies (44 patients) were selected through the PubMed-Medline archives (December 2002-April 2009), but only 26 (36 patients) matched our inclusion criteria. Left ventricular thrombus was detected in 32 patients (89%), whereas thromboembolic events occurred in 12 (33%). Morphological characteristics of thrombi are described through the article. Women >65 years of age presenting with deep/giant negative T-waves on admission ECG seem more likely to have thrombus-related embolic complications.
CONCLUSIONS: Important findings from this updated review indicate that LVT approximately occurs in 5% of the estimated worldwide SRC population, similar to historical incidence in patients with myocardial infarction. In a third of cases (approximately 1.6% of above guesstimate) nonfatal cardioembolic outcomes (brain ischemia in 75% of cases) have been documented. It is worthy considering early anticoagulant therapy, especially in patients at a higher risk of thromboembolic disease, irrespective of the presence of LVT at admission. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19913310     DOI: 10.1016/j.ijcard.2009.09.468

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Large apical thrombus due to Takotsubo cardiomyopathy.

Authors:  Geoffrey R Wong; Ross Roberts-Thomson; Saman Laleh Parvar; Adam J Nelson
Journal:  BMJ Case Rep       Date:  2016-02-15

2.  Stress cardiomyopathy complicated by left ventricular thrombi and cerebral infarctions in a patient with essential thrombocythemia.

Authors:  Seung Hwan Hwang; Kye Hun Kim; Hyun Ju Yoon; Young Joon Hong; Ju Han Kim; Young Keun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Cardiovasc Ultrasound       Date:  2011-06-30

3.  [Patient care in the acute phase of stress induced cardiomyopathy (Tako-Tsubo cardiomyopathy)--and thereafter?].

Authors:  V Kurowski; P W Radke; H Schunkert; C Burgdorf
Journal:  Herz       Date:  2010-06       Impact factor: 1.443

Review 4.  Anticoagulation and stress-induced cardiomyopathy.

Authors:  Saagar K Sanghvi; David M Harris
Journal:  J Thromb Thrombolysis       Date:  2019-01       Impact factor: 2.300

5.  Stroke Risk Following Takotsubo Cardiomyopathy.

Authors:  Nicholas A Morris; Monica Lin Chen; Oluwayemisi L Adejumo; Santosh B Murthy; Hooman Kamel; Alexander E Merkler
Journal:  Neurohospitalist       Date:  2020-06-08

6.  Targeting of the Akt/PKB kinase to the actin skeleton.

Authors:  V Cenni; A Sirri; M Riccio; G Lattanzi; S Santi; A de Pol; N M Maraldi; S Marmiroli
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

Review 7.  Takotsubo syndrome: Advances in the understanding and management of an enigmatic stress cardiomyopathy.

Authors:  Hernán David Mejía-Rentería; Iván J Núñez-Gil
Journal:  World J Cardiol       Date:  2016-07-26

8.  Takotsubo cardiomyopathy as a source of cardioembolic cerebral infarction.

Authors:  Sun Moon Kim; Shamik Aikat; Alison Bailey; Matthew White
Journal:  BMJ Case Rep       Date:  2012-09-21

9.  Incidence and predictors of stroke during the index event in an ethnically diverse Takotsubo cardiomyopathy population.

Authors:  A Dias; E Franco; S Janzer; Nikoloz Koshkelashvili; V Bhalla; Manolo Rubio; Sarah Amanullah; Kathy Hebert; Vincent M Figueredo
Journal:  Funct Neurol       Date:  2016 Jul-Sep

10.  Antiplatelet therapy in Takotsubo cardiomyopathy: does it improve cardiovascular outcomes during index event?

Authors:  Andre Dias; Emiliana Franco; Nikoloz Koshkelashvili; Vikas Bhalla; Gregg S Pressman; Kathy Hebert; Vincent M Figueredo
Journal:  Heart Vessels       Date:  2015-08-13       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.